Beyond DNA repair: the novel immunological potential of PARP inhibitors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Beyond DNA repair: the novel immunological potential of PARP inhibitors

Published:2019-03-04 Issue:2 Volume:6 Page:1-4
ISSN:2372-3556
Container-title:Molecular & Cellular Oncology
language:en
Short-container-title:Molecular & Cellular Oncology

Author:

Chabanon Roman M.¹²³⁴^ORCID,Soria Jean-Charles¹,Lord Christopher J.³⁴,Postel-Vinay Sophie¹²⁵

Affiliation:

1. Faculté de médicine, Université Paris Saclay, Université Paris-Sud, Le Kremlin Bicêtre, France

2. ATIP-Avenir group, Inserm Unit U981, Gustave Roussy, Villejuif, France

3. The Breast Cancer Now Toby Robins Breast Cancer Research Centre, The Institute of Cancer Research, London, UK

4. CRUK Gene Function Laboratory, The Institute of Cancer Research, London, UK

5. DITEP (Département d’Innovations Thérapeutiques et Essais Précoces), Gustave Roussy, Villejuif, France

Funder

Integrated Cancer Research Site

Fondation Philanthropia

Publisher

Informa UK Limited

Subject

Cancer Research,Molecular Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/23723556.2019.1585170

Reference11 articles.

1. PARP inhibitors: Synthetic lethality in the clinic

2. A high-throughput screen identifies PARP1/2 inhibitors as a potential therapy for ERCC1-deficient non-small cell lung cancer

3. Hyperprogressive Disease in Patients With Advanced Non–Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or With Single-Agent Chemotherapy

4. Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer

5. Mutational Landscape and Sensitivity to Immune Checkpoint Blockers

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deciphering the immune modulation through deep transcriptomic profiling and therapeutic implications of DNA damage repair pattern in hepatocellular carcinoma;Cancer Letters;2024-02

2. Programmable DNA Hydrogel Assisting Microcrystal Formulations for Sustained Locoregional Drug Delivery in Surgical Residual Tumor Lesions and Lymph Node Metastasis;Advanced Healthcare Materials;2023-12-12

3. A signal-seeking Phase 2 study of olaparib and durvalumab in advanced solid cancers with homologous recombination repair gene alterations;British Journal of Cancer;2023-06-26

4. Defining the Emergence of New Immunotherapy Approaches in Breast Cancer: Role of Myeloid-Derived Suppressor Cells;International Journal of Molecular Sciences;2023-03-08

5. PARP Inhibitors and Proteins Interacting with SLX4;Cancers;2023-02-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3